Opportunity Information: Apply for CDC RFA GH15 15830201SUPP16
Apply for CDC RFA GH15 15830201SUPP16
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance to the NTCP in Swaziland under PEPFAR" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Aug 02, 2016.
- Applicants must submit their applications by Oct 01, 2016 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $420,148.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This grant opportunity is a PEPFAR-supported program expansion supplement from the U.S. Centers for Disease Control and Prevention (CDC) aimed at strengthening Swaziland's ability to deliver high-quality, sustainable HIV and TB clinical services, while also boosting central-level technical assistance for the National Tuberculosis Control Program (NTCP). It is framed as a cooperative agreement, meaning CDC would expect substantial involvement in how the work is carried out, not just a simple transfer of funds. The funding is designed to help the Ministry of Health (MOH) and implementing partners push closer to universal coverage under the newer WHO 2013 recommendations, with a focus on improving the full continuum of care so that HIV testing, linkage, treatment initiation, and long-term retention work together smoothly and are better integrated within existing health system structures.
The need for the supplement is driven by the scale and severity of Swaziland's overlapping HIV and TB epidemics. The opportunity describes an adult HIV incidence estimated as high as 2.4 annually, with HIV prevalence at 31 among adults aged 18-49. TB incidence is extremely high at 1,380 per 100,000 people, and the country expected around 6,000 TB diagnoses by 2015. Co-infection is a central problem: roughly 75 to 80 percent of TB cases are also infected with HIV. The burden among pregnant women is highlighted as especially alarming, with HIV prevalence around 41, placing Swaziland among the highest globally. Even with progress already made, the narrative emphasizes that more work is required to reach universal coverage and to strengthen the MOH's long-term stewardship at national, regional, and facility levels so improvements are sustainable rather than dependent on short-term external support.
The supplement is closely aligned with national priorities set out in the extended National Strategic Framework (eNSF). In practical terms, it supports goals such as getting all children, adolescents, women, and men tested so they know their HIV status; improving availability and use of prevention and treatment services for key populations; eliminating new pediatric HIV infections while keeping mothers alive; and improving quality of life for people living with HIV by strengthening treatment, including treatment as prevention. The grant is built around the reality that Swaziland was preparing to scale up two major policy and service delivery shifts: routine viral load monitoring and "test and start" antiretroviral therapy (ART), meaning immediate treatment initiation after diagnosis in line with updated WHO guidance.
The funding has two main purposes. First, it supports viral load scale-up at the facility level by paying for training of clinical staff and procuring supplies needed to manage viral load results in routine care. Viral load monitoring is not just a laboratory upgrade; it requires clinicians and nurses to know how to interpret results, respond to elevated viral loads with adherence counseling or regimen changes when appropriate, and track follow-up testing so patients do not fall through the cracks. Second, the supplement expands "test and start" services to strengthen linkage to care and retention, with special attention to men, who are identified as a priority group because many HIV-positive men do not access traditional health services as consistently as women. The opportunity points to practical strategies such as expanding clinic hours and increasing community outreach to make services more accessible and more "male-friendly," recognizing that service hours, clinic environment, and outreach approaches can strongly influence whether men get diagnosed, start treatment quickly, and stay in care.
Geographically, the work is focused on 38 facilities in the Manzini region. The grant describes these funds as essential to avoid gaps in rollout that would leave large numbers of clients without access to key services. Specifically, it estimates that without sufficient support, 18,996 HIV-positive clients in those facilities would not receive viral load monitoring, and 326 HIV-positive individuals would not have access to immediate treatment under test and start. In other words, the supplement is positioned as a targeted investment to close a near-term funding and implementation gap so that policy changes translate into real service delivery improvements at the point of care.
Administratively, the opportunity is listed as CDC RFA GH15-15830201SUPP16 under CFDA 93.067 (Health). It was posted by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CGH). The original application closing date was October 1, 2016, with electronic submissions due by 11:59 p.m. Eastern Time. The award ceiling was $420,148, and CDC anticipated making one award, indicating this was likely intended as a supplement to an existing implementing mechanism rather than an open, multi-award competition. Eligibility is labeled broadly as "Others," with additional clarification referenced in the full eligibility text for the announcement.
Overall, this supplement is best understood as a focused effort to strengthen clinical quality and coverage during a critical transition period in Swaziland's HIV response: introducing routine viral load monitoring and implementing immediate ART initiation at scale. By combining staff training, essential supplies, service expansion, and targeted retention strategies for men, the opportunity aims to improve outcomes across the HIV care cascade and reinforce sustainable MOH leadership while also supporting TB program technical assistance in a setting where HIV/TB co-infection dominates the TB burden.
Frequently Asked Questions (FAQs)
What is this funding opportunity?
This opportunity is a PEPFAR-supported program expansion supplement from the U.S. Centers for Disease Control and Prevention (CDC). It is designed to strengthen Swaziland's ability to deliver high-quality, sustainable HIV and TB clinical services and to bolster central-level technical assistance for the National Tuberculosis Control Program (NTCP).
Is this a grant or a cooperative agreement?
It is framed as a cooperative agreement. That means CDC expects substantial involvement in how the work is carried out, rather than simply transferring funds with minimal federal engagement.
What health issues is the supplement trying to address?
The supplement targets Swaziland's overlapping HIV and TB epidemics, with emphasis on improving the HIV care continuum (testing, linkage, treatment initiation, and retention) and strengthening TB program support where HIV/TB co-infection is very high.
Why is this supplement considered necessary?
The need is driven by the scale and severity of HIV and TB in Swaziland and the push to reach universal coverage under WHO 2013 recommendations. The opportunity highlights very high HIV prevalence and TB incidence, plus a high share of TB cases co-infected with HIV, and notes that additional work is needed to make improvements sustainable under Ministry of Health (MOH) stewardship.
What HIV and TB burden figures are cited in the opportunity?
The narrative cites adult HIV incidence estimated as high as 2.4 annually and adult HIV prevalence at 31 among adults ages 18 to 49. TB incidence is cited as 1,380 per 100,000 people, with around 6,000 TB diagnoses expected by 2015. It also notes that roughly 75 to 80 percent of TB cases are co-infected with HIV, and that HIV prevalence among pregnant women is around 41.
What is the overall program goal?
The overall goal is to strengthen clinical quality and expand coverage during a transition period in Swaziland's HIV response, especially by introducing routine viral load monitoring and implementing "test and start" (immediate ART initiation after diagnosis) while reinforcing sustainable MOH leadership and supporting TB program technical assistance.
How does this supplement align with Swaziland's national priorities?
It is described as closely aligned with priorities in the extended National Strategic Framework (eNSF), including increasing HIV status knowledge through testing; improving prevention and treatment service availability and use for key populations; eliminating new pediatric HIV infections while keeping mothers alive; and improving quality of life for people living with HIV through stronger treatment approaches, including treatment as prevention.
What are the two main purposes of the funding?
The funding has two main purposes: (1) to support facility-level viral load scale-up through training and procurement of supplies needed to manage viral load results in routine care, and (2) to expand "test and start" services to strengthen linkage to care and retention, with special attention to men as a priority group.
What does the opportunity mean by "viral load scale-up"?
Viral load scale-up is described as more than a lab change. It includes training clinicians and nurses to interpret viral load results, respond to elevated viral loads (for example, with adherence counseling or regimen changes when appropriate), and track follow-up testing so patients remain in care and do not get lost to follow-up.
What does "test and start" mean in this announcement?
"Test and start" refers to immediate initiation of antiretroviral therapy (ART) after an HIV diagnosis, consistent with updated WHO guidance described in the opportunity.
Which populations receive special attention under this supplement?
The opportunity calls out men as a priority group for strengthened linkage and retention, noting that many HIV-positive men do not access traditional health services as consistently as women. It also highlights the burden among pregnant women in describing the country context.
What strategies are mentioned for improving services for men?
The opportunity points to strategies such as expanding clinic hours and increasing community outreach to make services more accessible and more "male-friendly," recognizing that service hours, clinic environment, and outreach approaches can influence diagnosis, rapid treatment initiation, and retention.
Where will the work be implemented?
The work is focused on 38 facilities in the Manzini region.
How does the announcement describe the consequences of not funding this supplement?
It estimates that without sufficient support, 18,996 HIV-positive clients in the targeted facilities would not receive viral load monitoring, and 326 HIV-positive individuals would not have access to immediate treatment under test and start.
What kind of activities are supported at the facility level?
Based on the description, supported activities include training clinical staff, procuring supplies needed to manage viral load results in routine care, expanding service delivery approaches to improve linkage and retention, and implementing operational changes such as expanded clinic hours and community outreach.
How does TB fit into the scope of this supplement?
In addition to HIV clinical service strengthening, the supplement aims to boost central-level technical assistance for the National Tuberculosis Control Program (NTCP), in a setting where HIV/TB co-infection is described as dominating the TB burden.
What does the opportunity say about sustainability?
The narrative emphasizes strengthening MOH long-term stewardship at national, regional, and facility levels so improvements are sustainable and not dependent on short-term external support.
What is the announcement number and CFDA listing?
The opportunity is listed as CDC RFA GH15-15830201SUPP16 under CFDA 93.067 (Health).
Which U.S. agency posted the opportunity?
It was posted by the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically CDC CGH.
What was the application deadline and submission time requirement?
The original application closing date was October 1, 2016. Electronic submissions were due by 11:59 p.m. Eastern Time.
How much funding was available?
The award ceiling was $420,148.
How many awards did CDC expect to make?
CDC anticipated making one award, which suggests it was likely intended as a supplement to an existing implementing mechanism rather than an open multi-award competition.
Who was eligible to apply?
Eligibility is labeled broadly as "Others," with additional clarification referenced in the full eligibility text for the announcement.
What is the program trying to improve across the HIV care cascade?
The supplement is focused on improving the full continuum of care so that HIV testing, linkage, treatment initiation, and long-term retention work together smoothly and are better integrated within existing health system structures.
What major policy and service delivery shifts were being scaled up?
The opportunity describes preparations to scale up routine viral load monitoring and implement "test and start" ART (immediate initiation after diagnosis) in line with WHO 2013 recommendations.
Browse more opportunities from the same agency: Department of Health and Human Services, Centers for Disease Control - CGH
Browse more opportunities from the same category: Health
Next opportunity: UWNPS Research Center Support
Previous opportunity: Program Expansion Supplement: Strengthening the SA National Department of Health to implement and evaluate evidence-based public health program, surveillance and disease control efforts under PEPFAR
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 15830201SUPP16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 15830201SUPP16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Program Expansion Supplement: Strengthening HIV/TB Laboratory Quality Management Systems and Services in the Kingdom of Swaziland under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15810201SUPP16 Funding Number: CDC RFA GH15 15810201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,628,300 |
| Program Expansion Supplement: Improving Quality of Care and Health Impact through Sustainable, Integrated, Innovative Information System Technologies in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH12 12500401SUPP16 Funding Number: CDC RFA GH12 12500401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520502SUPP16 Funding Number: CDC RFA GH11 11520502SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $876,491 |
| Program Expansion Supplement: Strengthening High Quality Laboratory Services Scale-up for HIV Diagnosis, Care, Treatment and Monitoring in Malawi under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 15510201SUPP16 Funding Number: CDC RFA GH15 15510201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,345,600 |
| Program Expansion Supplement: Strengthening Local Capacity to Provide Sustainable HIV-Related Care and Treatment Services in South Africa Apply for CDC RFA GH11 11090501SUPP16 Funding Number: CDC RFA GH11 11090501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $15,000,000 |
| Program Expansion Supplement: Technical Assistance Services to Countries Supported by the President's Emergency Plan for HIV/AIDS Relief (PEPFAR) and the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria Apply for CDC RFA GH13 13680302SUPP16 Funding Number: CDC RFA GH13 13680302SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $900,000 |
| National Hemophilia Program Coordinating Center Apply for HRSA 17 087 Funding Number: HRSA 17 087 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Improvement of Laboratory and Clinical Services, and Collaboration across the National HIV and TB Programs in Vietnam under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1711 Funding Number: CDC RFA GH17 1711 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $500,000 |
| Regional Hemophilia Network Apply for HRSA 17 074 Funding Number: HRSA 17 074 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Polio Eradication and Emergency Response in Priority Countries Apply for CDC RFA GH16 172102CONT17 Funding Number: CDC RFA GH16 172102CONT17 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Strengthening Local Capacity to Deliver Sustainable Quality-Assured Universal Coverage of Clinical HIV/TB Services and Provide Central Level Technical Assistance in Swaziland Natl AIDS Program under PEPFAR Apply for CDC RFA GH15 15820201SUPP16 Funding Number: CDC RFA GH15 15820201SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $355,549 |
| Cooperative Agreement on Immunization with United Nations Children's Fund (UNICEF) Apply for CDC RFA GH13 13020401SUPP16 Funding Number: CDC RFA GH13 13020401SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Program Expansion Supplement: Support for Strengthening and Expanding HIV/AIDS Surveillance Activities in SA under PEPFAR Apply for CDC RFA GH11 11540501SUPP16 Funding Number: CDC RFA GH11 11540501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,500,000 |
| Delivering Comprehensive Services to Achieve HIV Epidemic Control in Subnational Units in Nigeria under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1753 Funding Number: CDC RFA GH17 1753 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $200,000,000 |
| Building the Capacity of the Government of Suriname to Address Gaps in the HIV Continuum of Care for Key Populations and People Living with HIV (PLHIV) under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1774 Funding Number: CDC RFA GH17 1774 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $300,000 |
| Program Expansion Supplement for Planning, Implementation and Evaluation of Comprehensive HIV Prevention Programs in South Africa under PEPFAR Apply for CDC RFA GH11 11520501SUPP16 Funding Number: CDC RFA GH11 11520501SUPP16 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $3,604,705 |
| Supporting Local Indigenous Faith-Based Partners in Providing High Quality HIV Care, Prevention and Treatment Services and Improving Linkage and Retention in the Republic of Guyana under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1721 Funding Number: CDC RFA GH17 1721 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $465,000 |
| Support for Quality Facility and Community-based Antiretroviral Therapy (ART) for Adults and Children in Cameroon under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH17 1718 Funding Number: CDC RFA GH17 1718 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $10,000,000 |
| Strengthening Care and Support Services for Highly Vulnerable Populations, Orphans and Vulnerable Children and their Families, plus HIV Prevention for Youth in the Republic of Cote d'Ivoire under PEPFAR Apply for CDC RFA GH17 1755 Funding Number: CDC RFA GH17 1755 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $18,000,000 |
| Projecto de Saúde Para Todos (Health for All, or HFA) Apply for NFO RFA 654 16 000004 Funding Number: NFO RFA 654 16 000004 Agency: Agency for International Development, South Africa USAID-Pretoria Category: Health Funding Amount: $63,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 15830201SUPP16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.